ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,331Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 1692

$883K Total Retail Price of All Prescriptions

Rank: 57 out of 1692

826 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 826 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 826 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 13,953 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LISINOPRIL 587 460 1 2
METOPROLOL TARTRATE 540 458 2 10
FUROSEMIDE 536 435 3 7
SIMVASTATIN 520 399 4 1
HYDROCODONE-ACETAMINOPHEN 483 326 S3 5 6
LEVOTHYROXINE SODIUM 476 408 6 4
OMEPRAZOLE 412 288 7 5
SERTRALINE HCL 411 326 8 22
HYDROCHLOROTHIAZIDE 402 348 9 9
AMLODIPINE BESYLATE 399 335 10 3
PRAVASTATIN SODIUM 366 279 11 12
JANTOVEN 328 317 12 139
LOSARTAN POTASSIUM 286 267 13 17
CITALOPRAM HBR 281 233 14 21
DONEPEZIL HCL 269 255 15 29
RANITIDINE HCL 257 173 16 28
METFORMIN HCL 256 170 17 8
TRAMADOL HCL 241 170 18 16
GABAPENTIN 236 148 19 13
ZOLPIDEM TARTRATE 219 168 20 23
POTASSIUM CHLORIDE 215 170 21 20
ATORVASTATIN CALCIUM 193 170 22 11
WARFARIN SODIUM 180 169 23 14
ALLOPURINOL 168 143 24 30
ATENOLOL 156 139 25 15
ALBUTEROL SULFATE 148 112 26 115
METOPROLOL SUCCINATE 148 104 26 18
TRAZODONE HCL 147 96 28 33
FLUTICASONE PROPIONATE 146 79 29 27
PROAIR HFA 141 70 30 40
LEVEMIR FLEXPEN 139 72 31 149
TERAZOSIN HCL 138 134 32 128
SPIRIVA 130 106 33 44
KLOR-CON M20 128 79 34 48
MIRTAZAPINE 124 103 35 53
GLYBURIDE MICRONIZED 122 95 R 36 241
MELOXICAM 112 75 37 41
CLOPIDOGREL 111 100 38 43
ENALAPRIL MALEATE 110 81 39 71
TAMSULOSIN HCL 107 96 40 31
ALENDRONATE SODIUM 105 81 41 36
PLAVIX 98 91 42 66
PAROXETINE HCL 97 72 43 60
NOVOLOG FLEXPEN 95 65 44 169
CARVEDILOL 92 77 45 24
NAMENDA 88 88 46 50
CARBIDOPA-LEVODOPA 86 75 47 110
GLYBURIDE 84 53 R 48 82
ISOSORBIDE MONONITRATE ER 84 76 48 55
BISOPROLOL-HYDROCHLOROTHIAZIDE 83 66 50 118
DILTIAZEM 24HR ER 83 64 50 134
AZITHROMYCIN 80 64 52 34
PANTOPRAZOLE SODIUM 77 55 53 39
RISPERIDONE 74 73 54 77
PROMETHAZINE HCL 73 31 R 55 81
CLONIDINE HCL 70 58 56 46
LOSARTAN-HYDROCHLOROTHIAZIDE 70 56 56 38
TRIAMTERENE-HCTZ 68 47 58 61
DICLOFENAC SODIUM 68 52 58 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 52 58 19
POLYETHYLENE GLYCOL 3350 68 58 58 64
TRIAMCINOLONE ACETONIDE 66 58 62 105
CYCLOBENZAPRINE HCL 63 16 R 63 54
AMITRIPTYLINE HCL 61 41 R 64 58
MECLIZINE HCL 61 55 64 124
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 51 64 100
BENAZEPRIL HCL 61 56 64 69
SPIRONOLACTONE 60 54 68 74
NEXIUM 58 38 69 25
BUPROPION XL 57 21 70 235
GLIPIZIDE ER 57 41 70 87
FENTANYL 56 30 S2 72 88
CYMBALTA 55 47 73 51
OXYBUTYNIN CHLORIDE 55 32 73 162
DIGOXIN 54 51 75 85
FINASTERIDE 53 42 76 99
QUETIAPINE FUMARATE 53 24 76 62
CRESTOR 52 45 78 26
DIVALPROEX SODIUM 52 52 78 97
NADOLOL 50 43 80 260
LOVASTATIN 50 45 80 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.